CIK: 0002043476 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $135,435 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PALI | PALISADE BIO INC | 4,500,000 | $10,575 | 7.8% | $1.92 | 0.0% | COM | 696389402 |
| GPCR | STRUCTURE THERAPEUTICS INC | 90,000 | $6,260 | 4.6% | $69.55 | — | SPONSORED ADS | 86366E106 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ADMA | ADMA BIOLOGICS INC | 2,457,542 (+1.9%) | $44,826 (+26.7%) | 33.1% | $18.69 | -9.8% | COM | 000899104 |
| PRAX | PRAXIS PRECISION MEDICINES I | 33,237 (+5.5%) | $9,796 (+486.8%) | 7.2% | $58.36 | +219.1% | COM NEW | 74006W207 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 22,500 | $17,168 | 12.7% | — | — | PUT | 532457108 |
| NVDA | NVIDIA CORPORATION | 75,000 | $13,994 | 10.3% | — | — | PUT | 67066G104 |
| — | AKERO THERAPEUTICS INC | 232,446 | $11,037 | 8.1% | $27.82 | — | — | 00973Y108 |
| NRXPW | NRX PHARMACEUTICALS INC | 3,000,000 | $4,455 | 3.3% | $1.49 | — | — | 629444118 |
| GAME | GAMESQUARE HLDGS INC | 250,000 | $170 | 0.1% | $0.99 | -41.4% | — | 36468G103 |
| INSM | INSMED INC | 158 | $23 | 0.0% | $72.02 | +153.4% | — | 457669307 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SGHT | SIGHT SCIENCES INC | 920,000 (-1.1%) | $7,296 (+128.0%) | 5.4% | $4.05 | +57.9% | COM | 82657M105 |
| APGE | APOGEE THERAPEUTICS INC | 20,000 (-42.9%) | $1,510 (+8.6%) | 1.1% | $43.86 | +43.6% | COM | 03770N101 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CLLS | CELLECTIS S A | 3,281,501 | $15,882 | 11.7% | $1.77 | — | SPON ADS | 15117K103 |
| ZLAB | ZAI LAB LTD | 400,000 | $7,056 | 5.2% | $26.19 | — | ADR | 98887Q104 |
| TSHA | TAYSHA GENE THERAPIES INC | 1,800,556 | $9,903 | 7.3% | $2.04 | +138.1% | COM SHS | 877619106 |
| SYRE | SPYRE THERAPEUTICS INC | 100,000 | $3,276 | 2.4% | $23.56 | +10.9% | COM NEW | 00773J202 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 175,706 | $5,976 | 4.4% | $13.84 | +132.7% | COM NEW | 045396207 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 135,000 | $3,105 | 2.3% | $37.33 | -11.9% | COM | 90400D108 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 1,500,000 | $4,095 | 3.0% | $7.88 | -70.6% | COM | 462260100 |
| ORKA | ORUKA THERAPEUTICS INC | 75,000 | $2,273 | 1.7% | $15.19 | +83.4% | COM | 687604108 |
| AURA | AURA BIOSCIENCES INC | 572,576 | $3,121 | 2.3% | $8.79 | -32.4% | COM | 05153U107 |
| REPL | REPLIMUNE GROUP INC | 50,000 | $486 | 0.4% | — | — | CALL | 76029N106 |